identifying low- and high-risk aml
Published 2 years ago • 962 plays • Length 3:16Download video MP4
Download video MP3
Similar videos
-
2:19
identifying high-risk aml
-
2:13
high-risk aml: the 2022 eln risk classification and challenges in this patient population
-
2:31
updates in the diagnosis, risk stratification & treatment of aml: who, icc, and eln classifications
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
3:51
assessing high-risk aml
-
8:34
aml/cft process simplified: risk management(part 1)
-
7:46
updates in aml treatment and research from asco 2023
-
4:30
which gene mutations are categorized as low, intermediate and high risk aml? #aml
-
1:34
the importance of quickly spotting the signs of aml
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
2:58
feasibility and safety of early discharge in nd aml following intensive induction therapy
-
3:35
identifying risk factors for severe covid-19 in patients with aml, mds and all
-
3:47
the impact of cytogenetic-risk stratification on aml outcomes
-
2:45
continuity of care for patients with hematological predispositions to aml
-
3:13
validation of 2022 diagnostic & prognostic classifications of aml
-
2:47
incidence & clinical significance of clonal hematopoiesis in healthy vs aml patients
-
1:52
aml: the cytogenetic risk score
-
2:18
molecular profiling and risk classification of patients with mpns and splanchnic vein thromboses
-
2:57
the importance of analyzing cytogenetic risk in patients with aml undergoing haploidentical sct
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
2:43
gemtuzumab ozogamicin in frontline aml therapy